Helix BioPharma Corp. announced a private placement financing of 16,655,557 common shares at a price of CAD 0.18 per common share for proceeds of CAD 2,998,000 on August 15, 2023. The common shares issued pursuant are subject to a statutory hold period of four months and one day ending on December 16, 2023, in accordance with applicable securities law.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.26 CAD | +20.93% | +8.33% | +23.81% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+23.81% | 38.3M | |
+49.21% | 56.95B | |
+39.98% | 40.26B | |
-6.86% | 39.32B | |
-4.42% | 28.37B | |
+12.00% | 26.45B | |
-18.27% | 19.41B | |
+29.57% | 12.54B | |
+25.41% | 12.21B | |
-0.35% | 12.15B |
- Stock Market
- Equities
- HBP Stock
- News Helix BioPharma Corp.
- Helix BioPharma Corp. announced that it expects to receive CAD 2.998 million in funding